Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$28.05 - $37.69 $471,240 - $633,192
-16,800 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$24.52 - $40.23 $37,932 - $62,235
-1,547 Reduced 8.43%
16,800 $661,000
Q4 2020

Feb 02, 2021

SELL
$19.89 - $32.99 $7,956 - $13,196
-400 Reduced 2.13%
18,347 $417,000
Q3 2020

Nov 05, 2020

BUY
$21.54 - $29.53 $403,810 - $553,598
18,747 New
18,747 $425,000

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $600M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.